Adoptive immunotherapy with tumor-infiltrating T lymphocytes - Simon Turcotte
Sept 12th, 2022 - Adoptive immunotherapy with tumor-infiltrating T lymphocytes: developing new cell products and initiating a clinical program for solid cancer patients - Simon Turcotte, MD, MSc, FRCSC
▶︎
Adoptive T cell Therapy for Metastatic Melanoma
▶︎
Current & Future Role of Anktiva (N-803): Dr. Patrick Soon-Shiong
▶︎
T-Cell Memory and Exhaustion
▶︎
Why Can’t We Cure Cancer? A National Conversation | Full CUOMO Special Edition 2/27
▶︎
Penetrating Solid Tumors with CAR Immune Cells
▶︎
Immuno-oncology: Cold to Hot Tumours
▶︎
Immune Checkpoint Blockade in Cancer Therapy
▶︎
Engineered T Cells for Cancer
▶︎
Introduction to Immunotherapy (Immunotherapy Documentary Part I)
▶︎
Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers
▶︎
Breaking Myths: What Really Fuels Cancer Growth, with Dr. Fung and Dr. Seyfried | TCP Ep. 71
▶︎
What is TIL therapy for cancer and how does it work? | Ohio State Medical Center
▶︎
The Science of Resilient Aging: AI, Cancer and Immune Health
▶︎
Pascal Touchon 🇫🇷 | Cell Therapy, Jeito, Kymriah | E49
▶︎
CAR T at UCLA: Driving the Progress of Engineered Cell Therapy | Sarah Larson, MD | UCLAMDChat
▶︎
Engineering Better CAR T Cells: An Interview with CRI STAR Yvonne Chen, PhD
▶︎
Curing metastatic solid tumours with immune checkpoint inhibitors by Professor James Larkin
▶︎
CAR-T Cells: Engineered Cancer Killers
▶︎
177 - The development of cancer immunotherapy and its promise for treating advanced cancers
▶︎